The Pharmacy Benefit Manger (PBM) industry, which is a critical player in transactions that facilitate the pricing and reimbursement of prescription drugs, has experienced a high level of vertical integration and aggregation of market power. Rujul Desai, Partner, Covington & Burling LLP, and Kendra Roberson, Partner, Faegre Drinker Biddle & Reath LLP, discuss the rise of PBMs and their role in drug pricing and the increasing scrutiny of the industry at the federal and state levels. Rujul and Kendra are co-authors of AHLA’s brand-new publication, Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice.Watch the conversation here.Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast